Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Novartis Says Talks for Prostate Cancer Treatment Fail to Secure Deal
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Novartis Says Talks for Prostate Cancer Treatment Fail to Secure Deal
Nov 15, 2024 11:08 AM
11:35 AM EST, 11/15/2024 (MT Newswires) --
Price: 103.27, Change: -0.13, Percent Change: -0.12
Previous page:
Gray Media Q3 sales top expectations on higher advertising revenue
Next page:
Rapid Micro Biosystems Q3 revenue beats estimates
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Gray Media Q3 sales top expectations on higher advertising revenue
Nov 7, 2025
Overview * Gray Media Q3 2025 revenue beats analyst expectations * Net loss for Q3 2025 beats analyst expectations * Company announced acquisitions and refinancing to enhance financial flexibility Outlook * Gray Media ( GTN ) expects Q4 core advertising revenue between $380 mln and $390 mln * Company anticipates Q4 retransmission consent revenue between $328 mln and $330 mln...
Rapid Micro Biosystems Q3 revenue beats estimates
Nov 7, 2025
Overview * Rapid Micro Biosystems ( RPID ) Q3 revenue grows 3% to $7.8 mln, slightly beating expectations * Net loss for Q3 was $11.5 mln, missing analyst expectations Outlook * Company raises full-year 2025 revenue guidance to at least $33 mln * Company expects meaningful contribution from multi-system order in Q4 2025 * Company sees continued growth in 2026...
Price cuts help more Americans start weight-loss drugs but maybe not stay on them
Nov 7, 2025
By Bhanvi Satija and Chad Terhune LONDON/LOS ANGELES (Reuters) -A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more Americans to give them a try, but the cost may still be too high to keep patients long term, U.S. obesity specialists said. President Donald Trump announced on Thursday that Novo Nordisk...
Emera's Q3 profit beats on Tampa Electric performance
Nov 7, 2025
Overview * Emera ( EMA ) Q3 adjusted EPS grows 9% yr/yr, beating analyst expectations * Company unveils C$20 bln five-year capital plan, focusing 80% on Florida investments * Strong operational performance at Tampa Electric drives Q3 results Outlook * Emera ( EMA ) plans C$20 bln capital investment from 2026-2030, focusing on Florida * Company extends 7-8% rate base...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP